The Hindu Business Line : Biocon to acquire IP assets of Nobex Corp

The IP acquisition, unprecedented among Indian companies, has cost Biocon $5 million, including the final bid amount of $4.1 million, royalties and creditor settlements in what could be called a not hotly contested bid.

The biotechnology major becomes the sole inventor of delivery technologies and processes for half a dozen pipeline drugs of Nobex. The two were working on global co-development and commercialisation of the revolutionary oral insulin tablet IN105 and a heart failure drug called BN054, both of them in advanced pre-clinical stages.

The other assets include Oratonin, an oral calcitonin in phase 1 trials for osteoporosis; Oral PTH (Para Thyroid Hormone) and APAZA, an oral small molecule drug in phase 1/2 trials for inflammatory bowel disease.

The products would be at least couple of years away and the potential returns from oral insulin alone could be huge, sources said.

Ms Kiran Mazumdar-Shaw, Biocon CMD, said, "This is truly a strategic acquisition which provides us with an immensely valuable IP platform. It also gives us full ownership of our ongoing oral insulin and oral BNP programmes. It also provides us access to additional innovative technologies and new therapeutic paradigms. We have acquired an intellectual property estate of nearly 300 patents and patent applications focussed on oral peptide therapeutics in the metabolic & cardiovascular segment. We propose to leverage these proprietary assets through a combination of licensing and co-development partnerships."

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
RNRL plans Rs 1,100-cr pref issue

Dhampur Sugar fixes GDR price at $4.81

Indian `John Doe' sued

ICSA product secures patent

Suryajyoti Spg converts warrants

Biocon to acquire IP assets of Nobex Corp

Universal Empire to invest Rs 1,750 cr

GAIL, HPCL seek level-playing field

Hindalco arm to raise funds

L&T ties up with Saudi Kanoo group

BSL, French co in tie-up

Nortel, Bharti sign 5-year services deal

Thomas Cook India looking at expansion

iGATE to expand footprint in India

Sanyo to increase presence in India

Bhai Mohan Singh: Pioneer of pharma